Cholera Vaccine Demand in 2024 Continues Overwhelming Supply Precision Vaccinations News – Precision Vaccinations

(Precision Vaccinations News)

As the global cholera epidemic enters another year, the World Health Organization (WHO) continues classifyingcholera's resurgenceas a grade 3 emergency, its highest internal level for emergencies.

And access to protective vaccines is decreasing.

On February 12, 2024, the WHO published its 11thmulti-country cholera outbreak External Situation Report, which confirmed the global cholera response continues to be affected by a critical shortage of Oral Cholera Vaccines (OCV).

From January 2023 to January 2024, urgent requests for OCV surged, with 76 million OCV doses requested by 14 countries, while only 38 million doses were available during that period.

The global stockpile of cholera vaccines is awaiting replenishment, and all production up to March 8, 2024, will be allocated to approved requests.

The U.S. CDCrecommends vaccination for people traveling to or living in areas of active cholera transmission.However, cholera vaccinations are not 100% effective.

Vaxchora, a single-dose, oral vaccine, is U.S. FDA-approvedfor use in people aged 264.

The WHO has approved three other OCVs.

Read the original:

Cholera Vaccine Demand in 2024 Continues Overwhelming Supply Precision Vaccinations News - Precision Vaccinations